Isoprinosine in classical acute viral hepatitis
- PMID: 82401
- DOI: 10.1007/BF01072462
Isoprinosine in classical acute viral hepatitis
Abstract
A prospective double-blind controlled study was performed on the effects of isoprinosine in 81 patients with clinical and histological features of classical acute viral hepatitis. Appetite was assessed daily. Serum alanine aminotransferase, aspartic aminotransferase, and bilirubin levels were assessed weekly. Changes in biochemical parameters, number of deaths, number of patients showing rise of aminotransferase levels despite treatment, and duration required for appetite to return to normal in each group were compared. Observation was continued for 4 weeks. Contrary to preliminary reports, no therapeutic benefit was demonstrated in any of these parameters. We concluded that isoprinosine was ineffective in the acute phase of classical acute viral hepatitis.
Similar articles
-
[Isoprinosine in acute viral hepatitis type A. Preliminary report].Rev Chil Pediatr. 1982 May-Jun;53(3):213-7. Rev Chil Pediatr. 1982. PMID: 6185974 Clinical Trial. Spanish. No abstract available.
-
[Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].Orv Hetil. 1993 May 9;134(19):1015-9. Orv Hetil. 1993. PMID: 7684118 Clinical Trial. Hungarian.
-
[Isoprinosine: therapeutic action and studies in recurrent herpes].Orv Hetil. 1980 Jun 8;121(23):1393-5. Orv Hetil. 1980. PMID: 6160447 Hungarian. No abstract available.
-
[Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. I. Clinical evaluation].Wiad Lek. 1987 Oct 15;40(20):1369-74. Wiad Lek. 1987. PMID: 2451357 Clinical Trial. Polish. No abstract available.
-
[Isoprinosine--a drug with antiviral and immunomodulating action].Wiad Lek. 1984 Sep 1;37(17):1355-61. Wiad Lek. 1984. PMID: 6084363 Review. Polish. No abstract available.
Cited by
-
Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1986 Nov;32(5):383-424. doi: 10.2165/00003495-198632050-00001. Drugs. 1986. PMID: 2431857 Review.
-
Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.Adv Ther. 2019 Aug;36(8):1878-1905. doi: 10.1007/s12325-019-00995-6. Epub 2019 Jun 5. Adv Ther. 2019. PMID: 31168764 Free PMC article. Review.